Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK

In people with Type 2 diabetes, cardiovascular disease is a leading cause of morbidity and mortality. Thus, as well as controlling glucose, reducing the risk of cardiovascular events is a key goal. The results of cardiovascular outcome trials have led to updates for many national and international g...

Descripción completa

Detalles Bibliográficos
Autores principales: Bain, S. C., Bakhai, A., Evans, M., Green, A., Menown, I., Strain, W. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771802/
https://www.ncbi.nlm.nih.gov/pubmed/31254356
http://dx.doi.org/10.1111/dme.14058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771802/
https://www.ncbi.nlm.nih.gov/pubmed/31254356
http://dx.doi.org/10.1111/dme.14058

Ejemplares similares